What is your approach to monitoring patients with cardiac sarcoid while tapering immunosuppression?

Monitoring of patients with cardiac sarcoidosis (CS) is critical to optimizing therapy and improving outcomes.

Once a decision has been made to institute immunosuppressive therapy, it is important that the efficacy of therapy is demonstrated and that the duration of therapy is guided by the response...